Newcastle University: FibroFind Acquired to Drive Global Growth in Drug Development
May 15, 2025
May 15, 2025
NEWCASTLE UPON TYNE, England, May 15 -- Newcastle University issued the following news:
* * *
FibroFind acquired to drive global growth in drug development
FibroFind, a Newcastle University spin-out, has been acquired by private equity firm Vespa Capital in a move set to accelerate the company's international growth.
The company, which brings decades of academic research into the commercial drug development space, is a recognised leader in . . .
* * *
FibroFind acquired to drive global growth in drug development
FibroFind, a Newcastle University spin-out, has been acquired by private equity firm Vespa Capital in a move set to accelerate the company's international growth.
The company, which brings decades of academic research into the commercial drug development space, is a recognised leader in . . .